These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27534745)

  • 21. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
    Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
    Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
    Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
    Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Sci Rep; 2021 Apr; 11(1):7765. PubMed ID: 33833390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between embB Codon 306 Mutations, Phenotypic Resistance Profiles, and Genotypic Characterization in Clinical Mycobacterium tuberculosis Isolates from Hebei, China.
    Li Y; Wang Y; Zhang Z; Gao H; Wang H; Cao J; Zhang S; Liu Y; Lu J; Xu Z; Dai E
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7295-7302. PubMed ID: 27671062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex.
    Klotoe BJ; Molina-Moya B; Gomes HM; Gomgnimbou MK; Oliveira Suzarte L; Féres Saad MH; Ali S; Dominguez J; Pimkina E; Zholdybayeva E; Sola C; Refrégier G
    J Microbiol Methods; 2018 Sep; 152():10-17. PubMed ID: 29913189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
    Mujuni D; Kasemire DL; Ibanda I; Kabugo J; Nsawotebba A; Phelan JE; Majwala RK; Tugumisirize D; Nyombi A; Orena B; Turyahabwe I; Byabajungu H; Nadunga D; Musisi K; Joloba ML; Ssengooba W
    BMC Infect Dis; 2022 Apr; 22(1):363. PubMed ID: 35410160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
    Al-Hajoj S; Varghese B; Shoukri MM; Al-Omari R; Al-Herbwai M; Alrabiah F; Alrajhi AA; Abuljadayel N; Al-Thawadi S; Zumla A; Zignol M; Raviglione MC; Memish Z
    Antimicrob Agents Chemother; 2013 May; 57(5):2161-6. PubMed ID: 23459478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
    Lempens P; Decroo T; Aung KJM; Hossain MA; Rigouts L; Meehan CJ; Van Deun A; de Jong BC
    Int J Infect Dis; 2020 Nov; 100():357-365. PubMed ID: 32829049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
    Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G
    J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
    Kerubo G; Amukoye E; Niemann S; Kariuki S
    BMC Infect Dis; 2016 Oct; 16(1):583. PubMed ID: 27756241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhiça.
    Valencia S; Respeito D; Blanco S; Ribeiro RM; López-Varela E; Sequera VG; Saavedra B; Mambuque E; Morillo MG; Bulo H; Cobelens F; Macete E; Alonso PL; Caminero JA; García-Basteiro AL
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):446-451. PubMed ID: 28284261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
    Lisdawati V; Puspandari N; Rif'ati L; Soekarno T; M M; K S; Ratnasari L; Izzatun N; Parwati I
    BMC Infect Dis; 2015 Aug; 15():366. PubMed ID: 26297576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.